Article de Périodique
Change in alcohol consumption among French adults participating in Dry January: A 9-month prospective cohort study (2026)
Auteur(s) :
ROLLAND, B. ;
FRANCOIS, D. ;
HAESEBAERT, J. ;
DELILE, J. M. ;
SAVY, M. ;
TUBIANA-REY, B. ;
NAASSILA, M. ;
DE TERNAY, J. ;
LESPINE, L. F.
Année
2026
Page(s) :
art. 105436
Langue(s) :
Anglais
Domaine :
Alcool
Thésaurus géographique
FRANCE
Thésaurus mots-clés
ALCOOL
;
CAMPAGNE DE PREVENTION
;
ABSTINENCE
;
ADULTE
;
REDUCTION DE CONSOMMATION
;
USAGE PROBLEMATIQUE
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
CONSOMMATION
;
AUDIT
;
ETUDE LONGITUDINALE
Note générale :
The present study is part of the JANOVER project, which investigated participation and outcomes associated with the French Dry January 2024.
Résumé :
Background: Temporary alcohol abstinence campaigns, such as Dry January, are increasingly promoted as population-level initiatives to encourage reductions in alcohol consumption, yet evidence on longer-term changes in alcohol consumption following participation remains limited.
Methods: A longitudinal online survey was conducted among French adults participating in Dry January 2024. Participants completed a baseline survey at the end of December and follow-up assessments at 1 month (February), 3 months (April), and 9 months (October). The final cohort included 1,886 participants. Alcohol consumption was measured using the Alcohol Use Disorders Identification Test–Consumption (AUDIT-C) at baseline and at the 3-month and 9-month follow-ups. Changes in AUDIT-C scores were examined using linear mixed-effects models, while logistic regression models were used to identify baseline characteristics associated with reductions in drinking frequency, quantity, and heavy episodic drinking.
Results: AUDIT-C scores declined substantially from baseline to 3 months (Cohen's d = 0.68) and remained below baseline at 9 months (d = 0.57) despite a modest rebound, indicating sustained reductions in alcohol consumption. AUDIT-C scores decreased in all drinking risk groups, with larger reductions observed among participants classified as hazardous or harmful drinkers at baseline, compared to low-risk drinkers. Associations between baseline characteristics and alcohol reduction varied across outcomes and follow-up periods. Self-recognition of excessive drinking was the most consistent predictor of reductions across drinking frequency, quantity, and heavy episodic drinking, whereas higher baseline drinking risk was consistently associated with reductions in drinking quantity and heavy episodic drinking, but not drinking frequency.
Conclusions: Participation in Dry January in France was associated with moderate but sustained reductions in alcohol consumption, up to nine months after the campaign. These findings support that temporary abstinence campaigns are a complementary population-level strategy for reducing alcohol-related harm. [Author's abstract]
Highlights:
Dry January participation was associated with reduced alcohol consumption.
Reductions in consumption were largely sustained over nine months.
Higher-risk drinkers at baseline showed the greatest reductions in alcohol use.
Self-recognition of excessive drinking consistently predicted greater reductions.
Temporary abstinence campaigns may support population-level alcohol harm reduction.
Methods: A longitudinal online survey was conducted among French adults participating in Dry January 2024. Participants completed a baseline survey at the end of December and follow-up assessments at 1 month (February), 3 months (April), and 9 months (October). The final cohort included 1,886 participants. Alcohol consumption was measured using the Alcohol Use Disorders Identification Test–Consumption (AUDIT-C) at baseline and at the 3-month and 9-month follow-ups. Changes in AUDIT-C scores were examined using linear mixed-effects models, while logistic regression models were used to identify baseline characteristics associated with reductions in drinking frequency, quantity, and heavy episodic drinking.
Results: AUDIT-C scores declined substantially from baseline to 3 months (Cohen's d = 0.68) and remained below baseline at 9 months (d = 0.57) despite a modest rebound, indicating sustained reductions in alcohol consumption. AUDIT-C scores decreased in all drinking risk groups, with larger reductions observed among participants classified as hazardous or harmful drinkers at baseline, compared to low-risk drinkers. Associations between baseline characteristics and alcohol reduction varied across outcomes and follow-up periods. Self-recognition of excessive drinking was the most consistent predictor of reductions across drinking frequency, quantity, and heavy episodic drinking, whereas higher baseline drinking risk was consistently associated with reductions in drinking quantity and heavy episodic drinking, but not drinking frequency.
Conclusions: Participation in Dry January in France was associated with moderate but sustained reductions in alcohol consumption, up to nine months after the campaign. These findings support that temporary abstinence campaigns are a complementary population-level strategy for reducing alcohol-related harm. [Author's abstract]
Highlights:
Dry January participation was associated with reduced alcohol consumption.
Reductions in consumption were largely sustained over nine months.
Higher-risk drinkers at baseline showed the greatest reductions in alcohol use.
Self-recognition of excessive drinking consistently predicted greater reductions.
Temporary abstinence campaigns may support population-level alcohol harm reduction.
Affiliation :
Service Universitaire d’Addictologie de Lyon (SUAL), Le Vinatier Psychiatrie Universitaire Lyon Métropole, Bron, France
Service Universitaire d’Addictologie de Lyon (SUAL), Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
Université Claude Bernard Lyon 1, CNRS, INSERM, Centre de Recherche en Neurosciences de Lyon CRNL U1028 UMR5292, PSYR2, Bron, France
Direction de la Recherche Clinique et de l’Innovation (DRCI), Le Vinatier Psychiatrie Universitaire Lyon Métropole, Bron, France
Research on Healthcare Performance (RESHAPE), INSERM U1290, Hospices Civils de Lyon, Lyon, France
Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, France
Fédération Addiction, Paris, France
Association Addictions France, Paris, France
Groupe de Recherche sur l’Alcool et les Pharmacodépendances (GRAP), INSERM U1247, Université de Picardie Jules Verne, Amiens, France
Service Universitaire d’Addictologie de Lyon (SUAL), Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
Université Claude Bernard Lyon 1, CNRS, INSERM, Centre de Recherche en Neurosciences de Lyon CRNL U1028 UMR5292, PSYR2, Bron, France
Direction de la Recherche Clinique et de l’Innovation (DRCI), Le Vinatier Psychiatrie Universitaire Lyon Métropole, Bron, France
Research on Healthcare Performance (RESHAPE), INSERM U1290, Hospices Civils de Lyon, Lyon, France
Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, France
Fédération Addiction, Paris, France
Association Addictions France, Paris, France
Groupe de Recherche sur l’Alcool et les Pharmacodépendances (GRAP), INSERM U1247, Université de Picardie Jules Verne, Amiens, France
Historique